Abstract
SummaryThe enhancement of vascular activator- and urokinase-induced lysis of human plasma clots following preincubation of the plasma with flufenamate - a fibrinolytic organic anion - was assessed by thrombelastography. Thrombelastograms clearly demonstrated an acceleration of activator-induced clot lysis by flufenamate. Based on the results of previous studies it is concluded that this chemical potentiation of activator-induced fibrinolysis results from inactivation of inhibitors of the fibrinolytic enzyme system, especially antiactivator, by the compound. The potential therapeutical implications of these findings are discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
